The Motley Fool
24 Oct 2026, 17:11 UTC · 1h ago
Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?
Impact · against what's priced in
The article provides no new catalysts for Abbott Laboratories, as its revenue growth and Exact Sciences acquisition are already reflected in the current valuation. UnitedHealth Group is mentioned only for a daily price movement and general business model description, offering no material updates to its fundamental outlook.
- ABT+0.00
Already priced in
- The price assumes
The $3 billion in 2026 sales contribution from the Exact Sciences acquisition





